Radiotherapy for Inflammatory Breast Cancer (IBC) in the Modern Multi-Modality Treatment Era: A Provincial Retrospective Review Over 12 Years |Biomedgrid

The primary objective of this retrospective review was to determine the locoregional recurrence rates in non-metastatic Inflammatory Breast Cancer (IBC) patients treated with modern multi-modal therapy. Secondary objectives included assessing the impact of hypofractionation on 5-year outcomes (LRC, OS, DFS, DMFS) and identifying predictors of loco-regional relapse to select patients who may benefit from dose escalation.